Axial Biotherapeutics

Axial Biotherapeutics

Axial Biotherapeutics is a biopharmaceutical company targeting neurological disorders such as Parkinson's and Autism via gut health.

Axial Biotherapeutics is a clinical-stage biopharmaceutical company that focuses on discovering and developing gut-restricted, small molecule therapeutics for central nervous system disorders.

Timeline

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Axial Biotherapeutics funding round, June 2019
10,000,000
June 2019
1 Result
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.